FindTrial
Sign In

Fluorine F 18 Tetrafluoroborate

OTHER2 trials

Sponsors

Mayo Clinic

Conditions

Differentiated Thyroid Gland CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial AdenocarcinomaRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRecurrent Endometrial Mixed Cell AdenocarcinomaRecurrent Endometrial Serous Adenocarcinoma

Phase 1

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Active, not recruitingNCT03120624
Mayo ClinicMetastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma +7
Start: 2017-09-15End: 2028-01-01Updated: 2026-02-04

Unknown Phase

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
RecruitingNCT05575440
Mayo ClinicDifferentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma
Start: 2022-04-22End: 2028-05-01Target: 24Updated: 2026-02-27

Related Papers

Abstract CT072: First in human (FIH) dose escalation studies of intravenous administration of VSV-IFNβ-NIS (Voyager-V1™) in Stage IV or recurrent endometrial cancer
Cancer Research2018-07-014 citations